Max Healthcare Institute (NSE:MAXHEALTH) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAXHEALTH Max Healthcare Institute Ltd NSE:MAXHEALTH
94 GF Score
Price ₹1,104.80
GF Value ₹1,444.93
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Max Healthcare Institute Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Max Healthcare Institute Valuation Rank Related Terms

NSE:MAXHEALTH
94GF Score
Max Healthcare Institute Ltd NSE:MAXHEALTH
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Max Healthcare Institute (NSE:MAXHEALTH) Overvalued in 2026?

Based on GuruFocus' analysis, Max Healthcare Institute stock appears to be undervalued. The current stock price of ₹1,104.80 is trading 23.5% below its estimated GF Value™ of ₹1,444.93. GuruFocus considers Max Healthcare Institute to be Modestly Undervalued.

Key valuation signals for NSE:MAXHEALTH:

  • Valuation Rank:
  • GF Value™: ₹1,444.93 vs. price of ₹1,104.80 (23.5% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the NSE:MAXHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Max Healthcare Institute Business Description

Other Exchanges 543220:India
Address Capital Cyberscape, Sector-59, 2nd Floor, Gurugram, HR, IND, 122 102
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
94GF Score

Get the complete analysis for NSE:MAXHEALTH

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,104.80
Price
₹1,444.93
GF Value